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Abstract
Neurogenin 3 (Ngn3), a proneural gene, regulates dendritogenesis and synaptogenesis in mouse hippocampal neurons.
Ngn3 is transiently exported from the cell nucleus to the cytoplasm when neuronal polarity is initiated, suggesting that the
nucleo-cytoplasmic transport of the protein is important for its action on neuronal development. In this study, we identified
for the first time a functional nuclear export sequence (NES2; 131YIWALTQTLRIA142) in Ngn3. The green fluorescent protein
(EGFP)-NES2 fusion protein was localized in the cytoplasm and its nucleo-cytoplasmic shuttling was blocked by the CRM1
specific export inhibitor leptomycin B. Mutation of a leucine residue to alanine (L135A) in the NES2 motif resulted in both
cytoplasmic and nuclear localization of the EGFP-NES2 fusion protein and in the nuclear accumulation of ectopic full-length
myc-Ngn3. In addition, point mutation of the leucine 135 counteracted the effects of Ngn3 on neuronal morphology and
synaptic inputs indicating that the cytoplasmic localization of Ngn3 is important for neuronal development.
Pharmacological perturbation of the cytoskeleton revealed that cytoplasmic Ngn3 is associated with microtubules.
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Introduction
Neurogenins (Ngn1, Ngn2 and Ngn3) are basic-helix-loop-helix
(bHLH) proteins, which define a subfamily of atonal-related genes
[1–3]. Ngn1 and Ngn2 function as proneural genes in the
peripheral nervous system and thus promote both neurogenesis
and notch-delta mediated lateral inhibition [4]. Ngn2 regulates
neuronal subtype identity in the cerebral cortex, promoting
glutamatergic cell fate [5,6]. Ngn2 is also expressed in the
progenitors that generate most dentate granule cells and has an
essential role in the development of the dentate gyrus [7].
Ngn3, the third member of the neurogenin family, is expressed
in the embryonic pancreas as well as in the developing central
nervous system [3,8–10]. Ngn3 acts as a genetic switch that
specifies an endocrine cell fate in pluripotent pancreatic [11–13]
and intestinal progenitor [14,15]. In the nervous system Ngn3
regulates gliogenesis in the developing vertebrate spinal cord [16],
neurogenesis in the retina [17] and neurogenesis and neuronal
subtype specification in the hypothalamus [9]. Ngn3 is also
involved in the regulation of neuronal development in the
hippocampus. Overexpression of Ngn3 in cultured hippocampal
neurons stimulates the outgrowth of new dendrites and induces an
increase in the ratio of excitatory/inhibitory synaptic terminals
[18,19]. In addition, we have previously shown that Ngn3 is
located not only in the cell nucleus but also in the perikaryon of
hippocampal neurons. Furthermore, Ngn3 is transiently exported
from the nucleus to the cytoplasm at critical periods of neuronal
development, when neuronal polarity is established [10], suggest-
ing that nucleo-cytoplasmic shuttling of Ngn3 is important for the
function of the protein. For that reason we have explored in this
study the mechanism by which Ngn3 is exported from the cell
nucleus.
In eukaryotes, the cell nucleus is separated from the cytoplasm
by a nuclear membrane that contains nuclear pore complexes,
which allow the transport of proteins and mRNAs across the
nuclear envelope [20,21]. This process requires the proteins
importin or exportin [22,23]. Importins and exportins form
ternary complexes with Ran GTPase and recognize cargo proteins
that bear specific nuclear localization sequences (NLS) and nuclear
export sequences (NES), respectively. The majority of shuttling
proteins described to date possess a leucine-rich type of NES
similar to the one originally found in the HIV-1 Rev protein. This
type of NES is known to be a target recognized by the exportin
CRM1 [24]. The nuclear export of Rev protein is likely conducted
by binding NES to the exportin CRM1, because the shuttling of
the protein is inhibited by the CRM1 inhibitor leptomycin B
(LMB). The complex can then translocate to the cytoplasm, where
GTP is hydrolyzed to GDP, and the NES-containing protein is
released. The exportin-RanGDP complex diffuses back to the
nucleus where GDP is exchanged to GTP by Ran-guanine
nucleotide exchange factors. This process is energy-dependent as it
consumes one GTP per cycle. Some studies indicate that nucleo-
cytoplasmic shuttling is a novel regulatory mechanism of proteins,
which may participate in differentiation and in inhibition of cell
death [25]. In this study we have identified a functional nuclear
export sequence in Ngn3. In addition, a point mutation on this
sequence blocks both the nucleo-cytoplasmic transport of Ngn3 as
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well as the effect of Ngn3 on neuronal morphology and synaptic
inputs.
Results
Prediction of Ngn3 Nuclear Export Signals
Although it is well known that endogenous Ngn3 is localized
predominantly in the cell nucleus [16,26], we have recently shown
that Ngn3 also localizes in the perikarion of developing
hippocampal neurons and that the nuclear export pathway
utilized by Ngn3 is CRM1-dependent [10]. This pattern of
subcellular localization led us to assess whether Ngn3 has a nuclear
export signal. The simplest CRM1-dependent nuclear export
determinants are the so-called classic nuclear export signals
(NESs). These are short peptides comprising four spaced
hydrophobic residues (denoted W1–W4) and following the consen-
sus W1-(x)2–3-W
2-(x)2–3-W
3-x-W4, where x is an amino acid
preferentially negative charged, polar or small [27]. Therefore,
we searched for NES sequences in Ngn3 and identified two
potential NES motifs (NES1; 5PLDALTIQVS14 and NES2;
131YIWALTQTLRIA142) (Figure 1). NES1 is not a perfect NES
consensus because it has only one amino acid between the second
and third hydrophobic residues. Also the NES1 has greater acidity
consistent with the lower pI predicted using the ExPASy tool
(ProtParam) (3.80 for NES1 versus 8.75 for NES2). Therefore
NES2 is a more robust NES motif according with the consensus
sequence and it is very well conserved in a variety of species
(Figure 1).
The NES2 of Ngn3 Determines a Cytoplasmic Localization
and it is CRM1 Dependent
To establish whether these NESs can direct nuclear export, the
two sequence fragments corresponding to putative NES1 or NES2
were cloned in pEGFP-C1 vector. Neuronal cultures were
transfected with EGFP-NES1, EGFP-NES2 or EGFP expression
vector at 2 DIV and examined by fluorescence microscopy.
EGFP-NES1 was distributed in both the nucleus and the
cytoplasm, like unmodified EGFP (Figure 2, A, B and E). In
contrast, cells expressing EGFP-NES2 showed mainly cytoplasmic
fluorescence (Figure 2, C and E). Thus, the NES2, but not NES1,
of Ngn3 is sufficient to direct the exclusion of the EGFP fusion
constructs from the nucleus.
Leptomycin B (LMB), a specific inhibitor of the nuclear export
receptor CRM1, prevents the CRM1-NES interaction, thus
inducing the accumulation of shuttling proteins into the nucleus
[28]. To determine whether the nuclear export of EGFP fused to
NES1 and NES2 was CRM1 dependent, we examined the effect
of LMB in the subcellular localization of EGFP-NES1 and EGFP-
NES2. Fluorescence microscopy demonstrated that LMB did not
affect the subcellular distribution of EGFP and EGFP-NES1
(Figure 2E). In contrast, LMB increased EGFP-NES2 accumula-
tion in the cell nucleus (Figure 2, D and E). These observations
suggested that the subcellular localization of EGFP-NES2 is
regulated by CRM1. Therefore, we focused our next studies on
NES2.
Mutational Analysis of NES2
To explore the repercussion of NES2 amino acid sequence on
nuclear export activity, we generated point mutations within
NES2 in which one leucine or isoleucine residues were replaced
with alanine (I132A, L135A, L139A and I141A). The NE-
S2L135A mutant showed a significant increase in the accumula-
tion of NES2 in the cell nucleus, compared to wild-type NES2
(Figure 3, A–C). This demonstrates that the leucine 135 is the key
amino acid to export the protein out of the nucleus. The
subcellular localizations of EGFP-NES2L135A and EGFP-NE-
S2L139A were not substantially affected by LMB treatment
(Figure 3 C) suggesting that both leucines are important to bind
NES2 to CRM1.
Mutation of the NES2 (L135A) Leads to Decreased
Cytoplasmic Accumulation of Full-length Ngn3
To investigate the role of the NES2 in exporting full-length
Ngn3, we determined the effect of mutating this export sequence
on Ngn3 subcelluar localization. We used site-directed mutagen-
esis to generate an NES2-defective version of myc-Ngn3 (myc-
Ngn3-L135A) in which leucine 135 was mutated to alanine.
Primary neuronal cultures were transfected with plasmids
expressing myc, wild-type myc-Ngn3 or myc-Ngn3-L135A and
24 h after transfection, indirect immunostaining of myc was used
to detect the proteins (Figure 4, A, B and C). Cells were
cotransfected with EGFP to visualize their morphology (Figure 4,
D, E and F). In cells expressing myc-tag alone the fluorescence was
distributed similarly between the nucleus and the cytoplasm,
including the neurites (Figure 4, A and G). In the case of wild-type
myc-Ngn3, the myc fluorescence in the cytoplasm was relatively
decreased in comparison to cells transfected with myc-tag alone,
although significant cytoplasmic staining was detectable (Figure 4,
B and G). In contrast, cells expressing myc-Ngn3-L135A showed a
strong decrease in myc cytoplasmic localization (Figure 4, C and
G). This was evident by the reduction in the myc labeling of the
neurites, which were clearly visible with EGFP (Figure 4, C and F).
Figure 1. Comparison of putative nuclear export sequences
(NESs) in Ngn3 protein with consensus NES motifs and Ngn3
homologues of various species. The putative NES2 sequence is well
conserved in various species. In the consensus NES sequence, X
indicates any amino acid and Ø indicates a hydrophobic residue, such
as leucine, isoleucine, valine or methionine. Letters colored green
correspond to amino acids that are not conserved in the species
studied. Residues critical to NES activity are indicated by red letters.
doi:10.1371/journal.pone.0055237.g001
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Together, these results demonstrate that the NES2 reported here
mediates Ngn3 nuclear export.
Mutation of the NES2 (L135A) Impairs the Effects of Ngn3
Overexpression on the Development of Hippocampal
Neurons
To explore whether Ngn3 nucleo-cytoplasmic transport via
CRM1 is involved in neuronal maturation, we performed a
microscopic examination of dendritic processes and synaptogen-
esis in neuronal cultures at 4 DIV. Images in Figure 5, A–F are
representative examples of neurons co-expressing EGFP and myc
(Figure 5, A and D), wild type Ngn3 (Figure 5, B and E) or
mutated Ngn3-L135A (Figure 5 C and F). The cultures were
labeled with anti GFP and anti-synaptophysin I antibodies.
Quantitative analysis showed that overexpression of Ngn3 resulted
in a clear stimulation of dendrite initiation (Figure 5G) and an
increase in the total number of synaptic terminals (Figure 5H). The
change of leucine 135 by alanine in the Ngn3 sequence
counteracts the effects of Ngn3 on the number of primary
dendrites and the number of synaptic terminals. This suggests that
the cytoplasmic localization of Ngn3 is important for its action on
neuronal development.
Ngn3 Co-localizes with Microtubules but not with Actin
Filaments in Hippocampal Neurons
A study of Ngn3 sequence carried with PSORT II Prediction
program showed a moderate probability of cytoskeletal localiza-
tion. This cue, together with the fact that we have demonstrated its
localization and impact on dendrites, lead us to analyze if Ngn3 is
associated with components of the cytoskeleton. By immunocyto-
chemical assays of neurons permeabilized in PEM buffer (80 mM
PIPES, 2 mM EGTA, 1 mM MgCl2, pH 6.8) containing 0.05%
Triton X-100 to extract soluble cytosolic proteins, we found a
colocalization of Ngn3 with tubulin (Figure 6, B–D, F) but not with
actin filaments (Figure 6, A, E), which were enriched in the growth
cone of the cell processes (Figure 6 F).
To confirm the association between Ngn3 and microtubules,
neuronal cultures were treated with paclitaxel (Taxol), a drug
known to stabilize polymerized microtubules. The abundance of
Ngn3 was monitored in the soluble and insoluble fractions of the
cell lysates. As shown in Figure 7A, Ngn3 was enriched in the
insoluble fraction. To correlate the localization of Ngn3 to the
state of tubulin polymerization, the samples were also immuno-
blotted for bIII-tubulin. As expected, the treatment of the cultures
with paclitaxel resulted in the enrichment of b-tubulin in the
insoluble fraction (Figure 7A) corresponding to a stabilization of
microtubules. In addition, the treatment of the cultures with
paclitaxel resulted also in the enrichment of Ngn3 in the insoluble
fraction (Figure 7A). Similar results were obtained in brain
homogenates (Figure 7B). The treatment of brain homogenates
with paclitaxel resulted in the enrichment of b-tubulin and Ngn3
in the insoluble fraction (Figure 7B). The interaction between
soluble tubulin and Ngn3 was also observed by immunoprecip-
itation of the supernatants with anti-bIII-tubulin antibody and
Western blotting of the precipitate with anti-Ngn3 antibody
Figure 2. Activity of the putative nuclear export sequences (NESs) 1 and 2, with or without leptomycin B (LMB) treatment. (A–D)
Representative single optical sections acquired by confocal microscopy of neurons expressing NES1 or NES2 fused to green fluorescent protein
(EGFP). Cultured neurons were transfected at 2 DIV with expression plasmids for EGFP (A), EGFP-NES1 (B), or EGFP-NES2 (C and D) and after 16 h were
treated with or without 20 nM LMB for 3 h. EGFP fluorescence was analyzed by confocal microscopy. The relative fluorescence intensity in the
nucleus versus the cytoplasm was evaluated. In the absence of LMB (C) NES2 was enriched in the cytoplasm. Nuclear NES2 localization was increased
in the presence of LMB (D), indicating that the signal of active nuclear exports in the Ngn3 is the NES2. (E) Quantification of the subcellular
localization of Ngn3 in the cell nucleus versus the cytoplasm. Randomly selected fields containing cells counterstained with DAPI were digitalized and
the Mean Gray Value for Ngn3 immunostaining was measured in the nuclei and cytoplasm areas using ImageJ 1.37 v software. The graphs show the
mean+s.e.m. of the relative fluorescence intensity in nucleus versus cytoplasm. At least 70 cells from three experiments were counted for each
experimental condition. Significance levels were determined using a Student t-test; *** p,0.001 versus EGFP expressing neurons values; ###
p,0.001 of EGFP-NES2 transfection treated with LMB versus the same transfection not treated with LMB.
doi:10.1371/journal.pone.0055237.g002
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Figure 3. Mutational analysis of NES2. Cultured neurons were transfected at 2 DIV with expression plasmids for EGFP, EGFP-NES2, or EGFP-
mutated NES2. (A and B) Representative single optical sections acquired by confocal microscopy of neurons expressing EGFP-NES2 or EGFP-
NES2L135A. (C) Quantification of the subcellular localization of Ngn3 in the cell nucleus versus the cytoplasm. The only one mutation that was able to
modify the subcellular distribution of EGFP-NES2 was L135A. In the rest of the mutations tested the location of the fusion protein continued to be
mainly cytoplasmic and LMB sensitive (except for L139A that resulted LMB insensitive). The graphs show the mean+s.e.m. of the relative fluorescence
intensity in nucleus versus cytoplasm. At least 70 cells from three experiments were counted for each experimental condition. Significance levels were
determined using a Student’s t-test; *** p,0.001 versus EGFP expressing neurons values; ## p,0.01, ### p,0.001 versus the same transfection
not treated with LMB; ns, not significant.
doi:10.1371/journal.pone.0055237.g003
Figure 4. Point mutation in NES2 induces nuclear accumulation of full-length Ngn3. (A–F) Cultured neurons were co-transfected with
constructs encoding EGFP and full-length myc-tagged wild-type Ngn3 (myc-Ngn3), Ngn3 with leucine 135 mutated to alanine (myc-Ngn3-L135A) or
empty vector expressing myc-tag. After 16 h, double immunostaining was performed using an anti-myc antibody to determine subcellular
localization of wild-type and mutated myc-Ngn3 (A-C) and an anti-GFP antibody to visualize neurons at full (D-F). (G) Quantification of the relative
fluorescence in the cell nucleus versus the cytoplasm of neurons. Graphs show the results (mean+s.e.m.) of at least three experiments. Significance
levels were determined using a Student’s t-test; *** p,0.001 versus values of neurons transfected with plasmid expressing myc-tag.
doi:10.1371/journal.pone.0055237.g004
Nuclear Export Signal in Neurogenin3
PLOS ONE | www.plosone.org 4 January 2013 | Volume 8 | Issue 1 | e55237
(Fig. 7C). Graphs in Figure 7 represent the relative amount of
Ngn3 and the distribution of bIII-tubulin in the pellet and in the
soluble fraction under the two experimental conditions tested
in vivo and in vitro. Quantitative data are shown as the mean and
standard error (s.e.m.) and statistical analyses was assessed using
unpaired t-test. The levels of significance were denoted as
*p,0.05, **p,0.01.
Discussion
The scientific question we are addressing deals with the
mechanism by which Ngn3 is exported from the cell nucleus
during hippocampal neuronal differentiation. In this work we have
demonstrated that Ngn3 possesses a functional NES that is
necessary for its translocation to the cytoplasm, where Ngn3
associates with microtubules and regulates neuronal differentia-
tion. Our conclusion is based on three observations. First, the
sequence between amino acids 131 and 142 (NES2) closely fit the
consensus pattern of hydrophobic residue characteristics of NESs.
Second, this sequence was able to mediate nuclear export of an
EGFP fusion protein and the export was inhibited by treatment
with LMB. Third, point mutation of the leucine 135 in this
sequence abrogated export of EGFP-NES2 and myc-Ngn3
proteins and counteracted the effects of Ngn3 on neuronal
morphology and synaptic inputs. The most characterized func-
tional role of Ngn3 is its activity as a transcription factor in
endocrine cells and accordingly Ngn3 is localized in the cell
nucleus of different cell types [16,26]. Recently we have reported
that Ngn3 is also localized in the cytoplasm of hippocampal
neurons during specific developmental stages. Ngn3 does not
remain in the cytoplasm after being synthesized; it is first
transported into the cell nucleus and then is exported out again
to the cytoplasm, where it is localized in neuronal processes [10].
However, the mechanism for nuclear export of Ngn3 was
unknown.
The NES Motif in the Ngn3 Sequence
Classic NESs are also referred to as leucine-rich NESs, but
analyses of other export cargoes and randomization-and-selection
screens showed that isoleucine, valine, methionine or phenylala-
nine are also permitted at the hydrophobic positions [29–31].
Searching for NES motif in Ngn3 sequences we identified two
Figure 5. Mutation of the NES2 (L135A) counteracts the effects of Ngn3 overexpression on neuronal morphology and synaptic
inputs. (A–C) Hippocampal neuronal cultures were co-transfected with constructs encoding EGFP and full-length myc-tagged wild-type Ngn3 (myc-
Ngn3), Ngn3 with leucine 135 mutated to alanine (myc-Ngn3-L135A) or empty vector expressing myc-tag as control. After 16 h, double
immunostaining was performed using an anti-GFP antibody to visualize transfected neurons and an anti-synaptophysin I antibody to determine the
morphology and the total number of synapses of the transfected neurons. (D–F) Lower panels show the boxed regions at higher magnification (G)
Number of primary dendrites of the transfected neurons. (H) Counts of synaptophysin I immunoreactive terminals in contact with a neuron within a
circular region of interest (ROI) with a diameter of 100 mm and centered in the neuronal soma. Data are mean+s.e.m. and significance levels were
determined using ANOVA followed by the Bonferroni post hoc test; *** p,0.001 versus control neuron values and ### p,0.001 versus myc-Ngn3
expressing neuron values.
doi:10.1371/journal.pone.0055237.g005
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fragments that could function as NES according to published NES
consensus sequences [32,33]. Nevertheless only one of them,
NES2, was able to direct the exclusion of the EGFP-NES2 fusion
protein from the nucleus. The other one, NES1 did not exhibit
nuclear export activity, probably because it do not fit as well as
NES2 to the consensus sequence and also because it is a more
acidic sequence than NES2. In addition, our findings suggest that
the subcellular localization of EGFP-NES2 is regulated by CRM1,
because the shuttling of the protein to the cytoplasm, as well as the
shuttling of Ngn3, is inhibited by LMB [10]. Therefore, our data
are compatible with an active nuclear export of Ngn3 mediated by
an active NES located between amino acids 131 and 142.
Key Amino Acids to Bind NES2 to CRM1
To identify the specific amino acids that are responsible to bind
NES2 to CRM1, the four hydrophobic amino acids were changed
by alanine and its influence in the NES2 activity was studied. The
mutations I132A and I141A were well tolerated when NES2 is
fused to an exogenous reporter. The mutation L135A resulted in
the loss of the NES2 ability to direct the EGFP-NES2 protein to
the cytoplasm and in the loss of responsiveness to LMB treatment,
indicating that the leucine 135 is crucial for the NES2 binding to
CRM1. Interestingly, the mutation L139A did not change NES2
nuclear export activity but provoked the disappearance of the
sensibility to LMB. This suggests that such amino acid collaborates
in the NES2 binding to CRM1 and enhances NES function. In the
case of full length Ngn3, the point mutation L135A of the myc-
Ngn3 determines virtually only nuclear protein localization.
Therefore we can conclude that leucine 135 is the main amino
acid for the binding of Ngn3 to exportin and that Ngn3
translocation from the cell nucleus to the cytoplasm in neurons
is mediated by the exportin CRM1. This is in concordance with
previous data showing that Ngn3 is retained in the cytoplasm of
multiple endocrine neoplasia type 1 islet and pancreatic endocrine
tumor cells [34] and that tumor size is related with the level of
CRM1 expression [35].
It is of interest to note that L135A mutation had a stronger
inhibitory effect on the nucleo-cytoplasmic transport of full length
Ngn3 than on the nucleo-cytoplasmic transport of the NES2
fragment. The reason for this difference may be that Ngn3 has a
nuclear localization site (NLS) while NES2 does not. Therefore, in
the case of full-length protein the NLS promotes its translocation
to the nucleus. This may also explain why in cells transfected with
wild-type myc-Ngn3, the myc fluorescence in the cytoplasm was
Figure 6. Ngn3 co-localizes with microtubules and not with actin filaments. At 3 DIV, neurons were immunostained for Ngn3 (red) and
stained for actin with phalloidin (green) (panels A,E) or immunostained for Ngn3 (red) and tubulin (green) (panels B-D and F). (A and D)
Representative confocal images. (E and F) Detail of growth cones. Note the association of Ngn3 with microtubules. In contrast Ngn3 was clearly not
associated with actin filaments.
doi:10.1371/journal.pone.0055237.g006
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relatively decreased in comparison to cells transfected with myc-
tag alone.
Functional Consequences of Ngn3 Nucleo-cytoplasmic
Transport
The finding of Ngn3 shuttling between the cytoplasm and
nucleus raises the question of whether this nucleo-cytoplasmic
transport has a biological function. Other authors reported a
patient with two heterozygous mutations in Ngn3 and a novel
subtype of permanent neonatal diabetes associated with severe
malabsorptive diarrhea. One of these mutation results in the
substitution of leucine for proline at position 135. They also
showed that electroporation with wild-type Neurogenin 3 provokes
the differentiation of delaminating and hormone expressing cells
outside the normal pancreas, whereas electroporation with
Ngn3L135P had no detectable effect on the chicken endoderm
[36]. We have found that L135A mutation, which reduces the
nucelo-cytoplasmic transport of Ngn3, causes a decrease in the
number of the primary dendrites and in the number of synaptic
inputs. This finding suggests that nucleo-cytoplasmic translocation
of Ngn3 during neuronal development [10] is involved in the
initiation and growth of dendrites.
Ngn3 and the Cytoskeleton
The finding that the inhibition of nucleo-cytoplasmic transport
of Ngn3 reduces dendritic development leads us to analyze
whether Ngn3 may interact with components of the cytoskeleton.
Immunocytochemical analyses showed that Ngn3 colocalizes with
tubulin in cultured hippocampal neurons. The colocalization was
detected in the perikaryon and the neuronal processes, including
the growth cones. On the contrary, we did not detect colocaliza-
tion of Ngn3 with actin filaments. In addition, Ngn3 increased in
parallel with b-tubulin in the insoluble fraction of cell lysates from
neuronal cultures or brain homogenates that were treated with
paclitaxel to induce tubulin polymerization. Furthermore, the
interaction of Ngn3 with tubulin was confirmed by immunopre-
Figure 7. Pharmacological perturbation of the cytoskeleton suggests association of Ngn3 to tubulin and microtubules. (A) Cultured
neurons were untreated or treated with paclitaxel (Taxol; 20 mM) for 40 minutes; then cells were lysated and centrifuged. Proteins present in the
precipitate, that includes microtubules and associated proteins (P) and supernatant (S) were analyzed by Western blotting. Ngn3 is enriched in the
insoluble fractions and its concentration increases as polymerized tubulin does. (B) Embryonic mouse brains were homogenized and a high-speed
precipitate was resuspended and divided in two. Aliquots were left untreated or treated with 20 mM paclitaxel plus 1 mM GTP for 40 minutes at room
temperature. Microtubular fraction sedimented by centrifugation (P) and supernatant (S) were analyzed by Western blotting. (C) The supernatants (S)
of control (C) and paclitaxel (T) treated aliquots were immunoprecipitated (IP) with anti-bIII-tubulin antibody (or IgG control) to determine the
interaction of Ngn3 with soluble tubulin. Precipitates were analyzed by Western blotting with anti-Ngn3 antibody. Graphs show the quantification of
densitometry. Error bars show the mean+s.e.m. of three experiments. Significance levels were determined for the data sets connected by horizontal
lines using the Student’s t-test. * p,0.05, **p,0.01.
doi:10.1371/journal.pone.0055237.g007
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cipitation experiments. These findings suggest that Ngn3 is
associated with microtubules. Canonical microtubule binding
motifs are present in MAP and tau proteins [37], but we have
been unable to find such motifs in Ngn3. However, other proteins
that lack canonical microtubule binding motifs, such as kinesins
and myosins, are also able to associate to microtubules [38–40].
Furthermore, the interaction of Ngn3 with microtubules can be
indirect and mediated by intermediate proteins. Therefore, our
results suggest that the transient cytoplasmic accumulation of
Ngn3 in developing neurons may mediate the actions of this
molecule on the initiation of neuritogenesis.
Materials and Methods
Ethics Statement
CD1 mice were raised in the Cajal Institute and used to
generate embryos for this study. The day of vaginal plug was
defined as E0, and the mouse pups were born on E19 (P0). All
procedures for handling and killing the animals used in this study
were in accordance with the European Commission guidelines
(86/609/CEE) and were approved by the Bioethics Committee of
the ‘‘Consejo Superior de Investigaciones Cientı´ficas’’ (CSIC).
Permit number: 28079/31A (01/18/2011).
Antibodies
The following primary antibodies were used: chicken anti-bIII
tubulin (1:1000; Abcam, Cambridge, UK), mouse anti bIII-
tubulin (Tuj1; Covance, CA; 1:1000), mouse anti-synaptophysin I
(1:500; Progen, Heidelberg, Germany), mouse anti-myc-tag
(Roche, Indianapolis, IN, USA; 1:200), chicken anti-GFP
(1:1000; Abcam, Cambridge, UK) and mouse anti-Ngn3
(F25A1B3; 1:2000) obtained from the NICHD Developmental
Studies Hybridoma Bank (University of Iowa) with tyramide signal
amplification (TSA and Cy3-TSA, PerkinElmer Life Sciences,
Boston, MA) for immunostaining of Ngn3. To verify that the
labelling was caused specifically by the primary antibodies, these
were either omitted or replaced by similarly diluted normal serum
from the same species. Peroxidase, biotin, FITC, Cy2, Cy3-
conjugated secondary antibodies and peroxidase-conjugated
streptavidin were from Jackson Immuno Research (West Grove,
PA, USA) and Alexa 488-phalloidin (1:1000) was from Molecular
Probes (Leiden, Holland).
Hippocampal Neuronal Cultures and Incubation
Conditions
The hippocampus was dissected out from embryonic day 17
mouse embryos and dissociated to single cells after digestion with
trypsin (Worthington Biochemicals, Freehold, NJ) and DNase I
(Sigma-Aldrich, St. Louis, MO) [41]. Neurons were plated on 6-
wells plates or glass coverslips coated with poly-L-lysine (Sigma-
Aldrich) at a density of 300 neurons/mm2, and they were cultured
in Neurobasal supplemented with B-27 and GlutaMAX I
(Invitrogen, Crewe, United Kingdom). A 2–3 DIV, cultured cells
were transfected and treated with either 20 nM LMB (Sigma-
Aldrich) or 20 mM paclitaxel (TaxolTM; Sigma-Aldrich) for the
time indicated below. After the treatments, neurons were rinsed
twice with PEM buffer (80 mM PIPES, 2 mM EGTA, 1 mM
MgCl2, pH 6.8) and permeabilized with the same buffer
containing 0.05% Triton X-100 (37uC, 3 min). After two rinses
with PBS, cells were fixed with cold methanol (5 min, –20uC).
Parallel cultures were harvested to protein analysis by Western
blotting.
Plasmid Constructs and Mutagenesis
For the construction of wild-type EGFP-NES1 and EGFP-
NES2 constructs the following double-stranded oligonucleotides
(Table 1) were annealed and ligated in the XhoI-EcoRI restriction
sites of the expression vector pEGFP-C1 (Clontech, Palo Alto,
CA).
Mutations of the EGFP-NES2 expression plasmid were created
using the QuikChange II site-directed mutagenesis kit protocol,
according to the manufacturer’s specifications (Stratagene, La
Jolla, CA). All PCR-generated clones were confirmed by
sequencing. Primer sequences are specified in Table 2.
Construction of the wild-type myc-Ngn3 expression plasmid
(pCS2-myc-Ngn3) has been described previously [18]. The L135A
mutation of Ngn3 was created directly in the pCS2-myc-Ngn3
construct using the QuikChange II site-directed mutagenesis kit.
The primers used in this case are specified in Table 3. All the
plasmids were verified by DNA sequencing.
Transfection
Neurons were transfected at 3 DIV using the Effectene
Transfection Reagent (Qiagen GmbH, Hilden, Germany),
following the manufacturer’s instructions. Cells were transfected
Table 1. Double-stranded oligonucleotides used for the construction of wild-type EGFP-NES1 and EGFP-NES2 constructs.
NES1 5’-GATCTCGAGCTCCCTTGGATGCGCTCACCATCCAAGTGTCCT GAATTCTGC-3’
NES1_ antisense 5’-GCAGAATTCAGGACACTTGGATGGTGAGCGCATCCAAGGGAG CTCGAGATC-3’
NES2 5’-GATCTCGAGCTTACATCTGGGCACTGACTCAGACGCTGCGCA TAGCGTGAATTCTGC-3’
NES2_ antisense 5’-GCAGAATTCACGCTATGCGCAGCGTCTGAGTCAGTGCCCAGA TGTAAGCTCGAGATC-3’
doi:10.1371/journal.pone.0055237.t001
Table 2. Primer sequences used for construction of EGFP-
NES2 mutants.
I132A 5’-CTCAGATCTCGAGCTTACGCCTGGGCACTGACTCAGAC-3’
I132A_
antisense
5’-GTCTGAGTCAGTGCCCAGGCGTAAGCTCGAGATCTGAG-3’
L135A 5’-GCTTACATCTGGGCAGCGACTCAGACGCTGCG-3’
L135A_
antisense
5’-CGCAGCGTCTGAGTCGCTGCCCAGATGTAAGC-3’
L139A 5’-GGCACTGACTCAGACGGCGCGCATAGCGTGAATT-3’
L139A_
antisense
5’-AATTCACGCTATGCGCGCCGTCTGAGTCAGTGCC-3’
I141A 5’-GACTCAGACGCTGCGCGCAGCGTGAATTCTGCAG-3’
I141A_
antisense
5’-CTGCAGAATTCACGCTGCGCGCAGCGTCTGAGTC-3’
doi:10.1371/journal.pone.0055237.t002
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with plasmids and after 16 h of expression time the cultures were
fixed for immunostaining.
Microtubule Association Assays
To examine Ngn3-microtubule interaction in the cultures, cells
were treated with paclitaxel (Taxol; 20 mM) for 40 minutes,
homogenized in PEM buffer containing 0.05% Triton X-100 and
protease inhibitors (Roche Diagnostics, Mannheim, Germany) and
centrifuged at 4uC for 5 minutes at 10006g to eliminate the
nucleus and membrane fractions. Supernatants were centrifuged
at 4uC for 30 minutes at 100,0006g. The pellets (containing
microtubules and associated proteins) were then directly depoly-
merized in SDS-PAGE sample buffer while soluble proteins were
supplemented with 56 concentrated SDS-PAGE sample buffer.
Both fractions were separated by SDS-PAGE, blotted and
processed for immunodetection with anti-Ngn3 and anti-tubulin
antibodies.
To examine Ngn3-microtubule interaction in vitro, embryonic
mouse brains were homogenized in 10 volumes of PEM buffer
containing 0.05% Triton X-100 and protease inhibitors, using 50
strokes in a glass-Teflon homogenizer. The homogenate was
centrifuged at 16,0006g for 30 minutes at 4uC to eliminate the
nuclear and membrane fractions and the supernatant was spun at
100,0006g for 30 minutes at 4uC. The resulting pellet was
resuspended and divided in two. Aliquots were left untreated or
treated with 20 mM paclitaxel (plus 1 mM GTP) for 40 minutes at
RT. Aliquots were then centrifuged at 100,0006g for 30 minutes
at 4uC. The pellet and supernatant fractions were then collected
and analyzed by Western blotting.
Immunoprecipitation
The supernatants from the high speed centrifugation of the
brain homogeates were incubated overnight with mouse anti-bIII-
tubulin antibody or with a not relevant mouse ascetic liquid at
4uC. Protein G agarose beads were then added and the incubation
was maintained for 2 additional hours. The beads were washed
extensively and boiled in the SDS loading buffer without reducing
agent, and the precipitated proteins were detected by SDS-PAGE
and Western blotting.
Western Blotting
Proteins were resolved by SDS-PAGE and transferred onto
polyvinylidene difluoride membranes (Millipore Ibe´rica, Madrid,
Spain). The membranes were blocked in Tris-buffered saline
containing 0.3% Tween 20 and 5% fat-free dry milk and
incubated first with primary antibodies and then with horseradish
peroxidase-conjugated secondary antibodies. Specific proteins
were visualized with enhanced chemiluminescence detection
reagent according to the manufacturer’s instructions (Amersham,
GE Healthcare Europe GmbH, Barcelona, Spain). Densitometry
and quantification of the bands were carried out using the
Quantity One software (Bio-Rad, Hercules, CA).
Image Acquisition and Analysis of Labelled Hippocampal
Neurons
Images were acquired digitally using a 406 oil immersion
objective and fluorescence filters. Confocal analysis was performed
in a Leica (Bensheim, Germany) microscope. Photomicrographs
were stored and digitally processed with Adobe Photoshop, v. 7.0
(Adobe Systems, San Jose, CA). Only minor adjustments to
brightness and contrast were made. In order to quantify the Ngn3
nuclear localization signal by immunocytochemistry, randomly
selected fields containing cells counterstained with DAPI were
digitalized, and the Mean Gray Value for Ngn3 immunostaining
in the nucleus and cytoplasm was measured using ImageJ 1.37 v
software. The values were background subtracted using the
average Mean Gray Value of the preparation background in each
of the experimental conditions. Data were represented as relative
fluorescence intensity of the cell nucleus versus the cytoplasm of
each neuron. Primary dendrite number at 4 DIV (i.e., the number
of dendrites emerging from the soma) and synaptic terminal counts
were performed manually. A circular region of interest (ROI) with
a diameter of 100 mm was projected onto the labeled neuron, its
center roughly coinciding with the center of the soma. Synaptic
terminals contacting the perikaryon or the dendrites were counted
within the circular ROI. Dendrites broken at single or multiple
points were defined as fragmented dendrites. Quantitative data are
shown as the mean and standard error (mean+s. e. m.) from about
70 cells per experimental condition. Statistical analyses were
performed using GraphPad Prism 5 (GraphPad Software, Inc.,
San Diego, CA). The one-way analysis of variance (ANOVA) was
used for multiple statistical comparisons. When justified by the
ANOVA analysis, differences between individual group means
were analyzed by the Bonferroni post-hoc test. The Student t-test
was used to compare two independent groups.
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